Alan has had a distinguished, four-decade long career in healthcare, most recently as Chief Executive Officer of The Toledo Hospital. From 1998 to 2009 he was Chief Executive Officer of ProMedica Health Systems Inc., one of the largest healthcare systems in the Midwest. Under Mr. Brass’ leadership, ProMedica experienced significant growth and today operates 71 corporations, 283 facilities and 10 hospitals in northwest Ohio and southeast Michigan. Mr. Brass is a retired Member of American Hospital Association; OSU Board of Trustees; American College of Healthcare Executives; Council of Retired Directors for Children’s Miracle Network; Health Management Academy - Chief Executive Officer Forum Health System; National Association Children’s Hospitals & Related Institutions; Michigan Hospital Association and Ohio Hospital Association.
Mike Buck is president of the Medical Products division at Cardinal Health. In this role, Mike has global responsibility for the Cardinal Health brand product portfolio, including product R&D, strategy, marketing and related M&A activities. He leads initiatives to expand and deliver multiple product solutions in consumables as well as physician and clinician preference items across the care continuum, from acute to retail channels. Prior to joining Cardinal Health, he most recently served with Abbott Laboratories, including roles as vice president of Global Market Development, vice president of Licensing and Acquisitions and vice president of Venture Investing. He previously held commercial leadership roles at Novoste Corporation, Boston Scientific and Smith & Nephew.
Sami has over 20 years of operating and investing experience across a broad spectrum of areas in healthcare and medical technology. Currently, he leads investments in medical technology as a Partner at AppleTree Partners, a $1.67B firm with offices in New York, California, and Europe, focused on medical technology, biotechnology, pharmaceuticals, and healthcare services. Prior to joining Apple Tree Partners, Mr. Hamade was a Partner at Aberdare Ventures, and held critical operating roles at Advanced Cardiovascular Systems (ACS)/Guidant. Mr. Hamadé is also an inventor and recipient of the prestigious Boss Kettering Award for innovation.
Ben is widely considered among the world's leading experts in neuromodulation and electrical stimulation product development, having pioneered the world’s first defibrillator at Ventritex, the first FDA-approved brain stimulator and closed loop brain stimulator for epilepsy at Neuropace, and the first externally activated microstimulator at ATI. Mr. Pless brings over 25 years of experience in developing and bringing to market implantable medical devices. Currently, Mr. Pless is President and CEO of ATI. Previously he was the COO and CTO of NeuroPace, and Vice President of Product Development for Ventritex. He is a named inventor on over 100 patents and patent applications.
Ali Rezai, MD, Founder and Chief of Science
Click here for bio.
John Rice, PhD
John is a co-founder and Managing Partner of Triathlon Medical Ventures based in Cincinnati. He has 25 years of venture investing and 13 years of research and R&D management experience in biomedical science. Previously, John spent 14 years as Managing Director of Senmed Medical Ventures, and 13 years with Battelle Memorial Institute in various research, research management, and business development capacities. Mr. Rice is a member and / or Chairman of the boards of BioOhio, the Global Cardiovascular Innovation Center, the Investment Advisory Board of the Harrington Discovery Institute, the Industry Advisory Board of the Case - Coulter Partnership at Case Western Reserve, the CincyTech Advisory Board, the Innovation Fund Board at Children's Hospital Medical Center, and the Board of Trustees of Edison Biotechnology Institute of Ohio University.
Geoff is an Executive Vice President of Medtronic and President of Medtronic’s Restorative Therapies Group, which includes its global Neuromodulation business. Previously, Geoff had responsibility for leading the development of Medtronic's global strategic plan, business development and acquisition integration for the company. Geoff also serves as a member of the Company's Executive Committee. Prior to joining Medtronic, Geoff served as Managing Director of Business Development at GE Healthcare, where he was responsible for global business development efforts, including acquisitions, divestitures, joint ventures and equity investments.
Kevin Wasserstein, Founder & CEO
Click here for bio.
Caroline Whitacre, PhD
Carol is OSU's Vice President for Research and Professor of Microbial Infection & Immunity. She is responsible for strategic planning and infrastructure support for OSU's $966 M annual research program. Formerly she served as Associate Vice President for Health Sciences Research and Vice Dean for Research in the College of Medicine from 2001-2008.